Pancreatic Cancer Research

ResearcherIpsen (France)No recent work listed

Sandrine Barbier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3370-2346; OpenAlex author ID A5028295023. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer. Co-author DOI 10.1007/s40487-022-00215-2↗
  2. Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models. Co-author DOI 10.3390/cancers13102473↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Florence Meyer-Losic · 1 shared paper, 2023 · strength 0.15
  2. Julie Roques · 1 shared paper, 2021 · strength 0.10
  3. Rémy Nicolle · 1 shared paper, 2021 · strength 0.10
  4. Odile Gayet · 1 shared paper, 2021 · strength 0.10
  5. Nicolas Alejandro Fraunhoffer · 1 shared paper, 2021 · strength 0.10
  6. Abdessamad El Kaoutari · 1 shared paper, 2021 · strength 0.10
  7. Owen Hoare · 1 shared paper, 2021 · strength 0.10
  8. Juan Iovanna · 1 shared paper, 2021 · strength 0.10
  9. Nelson Dusetti · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.